- NCIt
- C9418
Loading cancer entity…
Loading cancer entity…
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (6)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04242238 | Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas | completed | Phase 1 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 28, 2025 | clinicaltrials |
| NCT06535997 | Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE(PRIMHADRON) | completed | — | 62 | Hospices Civils de LyonOTHER | 1 | Aug 6, 2025 |
| clinicaltrials |
| NCT03951571 | Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma | completed | Phase 2 | 88 | Fudan UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT01374672 | Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma | completed | — | 20 | Children's Oncology GroupNETWORK | 1 | May 12, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Aug 28, 2025source: clinicaltrials